Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease

Stephen M. Watt(Wellcome Sanger Institute), Louella Vasquez(Wellcome Sanger Institute), Klaudia Walter(Wellcome Sanger Institute), Alice Mann(Wellcome Sanger Institute), Kousik Kundu(University of Cambridge), Lu Chen(University of Cambridge), Ying Sims(Wellcome Sanger Institute), Simone Ecker(CRUK Lung Cancer Centre of Excellence), Frances Burden(National Health Service), Samantha Farrow(National Health Service), Ben W. Farr(Wellcome Sanger Institute), Valentina Iotchkova(European Bioinformatics Institute), Heather Elding(Wellcome Sanger Institute), Daniel G. Mead(Wellcome Sanger Institute), Manuel Tardáguila(Wellcome Sanger Institute), Hannes Ponstingl(Wellcome Sanger Institute), David Richardson(European Bioinformatics Institute), Avik Datta(European Bioinformatics Institute), Paul Flicek(European Bioinformatics Institute), Laura Clarke(European Bioinformatics Institute), Kate Downes(National Health Service), Tomi Pastinen(Children's Mercy Hospital), Peter Fraser(Florida State University), Mattia Frontini(National Health Service), Biola M. Javierre(Babraham Institute), Mikhail Spivakov(Babraham Institute), Nicole Soranzo(University of Cambridge)
Nature Communications
April 16, 2021
Cited by 74Open Access
Full Text

Abstract

Neutrophils play fundamental roles in innate immune response, shape adaptive immunity, and are a potentially causal cell type underpinning genetic associations with immune system traits and diseases. Here, we profile the binding of myeloid master regulator PU.1 in primary neutrophils across nearly a hundred volunteers. We show that variants associated with differential PU.1 binding underlie genetically-driven differences in cell count and susceptibility to autoimmune and inflammatory diseases. We integrate these results with other multi-individual genomic readouts, revealing coordinated effects of PU.1 binding variants on the local chromatin state, enhancer-promoter contacts and downstream gene expression, and providing a functional interpretation for 27 genes underlying immune traits. Collectively, these results demonstrate the functional role of PU.1 and its target enhancers in neutrophil transcriptional control and immune disease susceptibility.


Related Papers

No related papers found

Powered by citation graph analysis